Evidence map›Paper›PMID 22379458›Full record

ArticleCurrent neuropharmacology2011

Central nervous system vasculitis: still more questions than answers.

Marco A Alba, Georgina Espígol-Frigolé, Sergio Prieto-González, Itziar Tavera-Bahillo, Ana García-Martínez, Montserrat Butjosa, José Hernández-Rodríguez, Maria C Cid

Open access · bronzeAbstract read
In one paragraph

Article in Current neuropharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Large-vessel vasculitis.Nature reviews. Disease primers · 2022
    Review
  9. FusedRadiology case reports · 2021
    Article
  10. Article
  11. Imaging of Lyme Neuroborreliosis: A Pictorial Review.Open forum infectious diseases · 2020
    Review
  12. Article
  13. Article
  14. Endothelins in inflammatory neurological diseases.Pharmacology & therapeutics · 2019
    Review
  15. Primary angiitis of the central nervous system: diagnosis and treatment.Therapeutic advances in neurological disorders · 2018
    Review
  16. Review
  17. A Closer Look at Angiitis of the central nervous system.Neurosciences (Riyadh, Saudi Arabia) · 2017
    Article
  18. Extensive and Progressive Cerebral Infarction afterKorean journal of critical care medicine · 2017
    Article
  19. Review
  20. Giant cell arteritis: ophthalmic manifestations of a systemic disease.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marco A AlbaVasculitis Research Unit, Department of Systemic Autoimmune Diseases, Hospital Clinic, University of Barcelona, Institut d´Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Villarroel 170, 08036 Barcelona, Spain.
Georgina Espígol-Frigolé
Sergio Prieto-González
Itziar Tavera-Bahillo
Ana García-Martínez
Montserrat Butjosa
José Hernández-Rodríguez
Maria C Cid
Universitat de Barcelona · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The central nervous system (CNS) may be involved by a variety of inflammatory diseases of blood vessels. These include primary angiitis of the central nervous system (PACNS), a rare disorder specifically targeting the CNS vasculature, and the systemic vasculitides which may affect the CNS among other organs and systems. Both situations are severe and convey a guarded prognosis. PACNS usually presents with headache and cognitive impairment. Focal symptoms are infrequent at disease onset but are common in more advanced stages. The diagnosis of PACNS is difficult because, although magnetic resonance imaging is almost invariably abnormal, findings are non specific. Angiography has limited sensitivity and specificity. Brain and leptomeningeal biopsy may provide a definitive diagnosis when disclosing blood vessel inflammation and are also useful to exclude other conditions presenting with similar findings. However, since lesions are segmental, a normal biopsy does not completely exclude PACNS. Secondary CNS involvement by systemic vasculitis occurs in less than one fifth of patients but may be devastating. A prompt recognition and aggressive treatment is crucial to avoid permanent damage and dysfunction. Glucocorticoids and cyclophosphamide are recommended for patients with PACNS and for patients with secondary CNS involvement by small-medium-sized systemic vasculitis. CNS involvement in large-vessel vasculitis is usually managed with high-dose glucocorticoids (giant-cell arteritis) or glucocorticoids and immunosuppressive agents (Takayasu's disease). However, in large vessel vasculitis, where CNS symptoms are usually due to involvement of extracranial arteries (Takayasu's disease) or proximal portions of intracranial arteries (giant-cell arteritis), revascularization procedures may also have an important role.

Indexed as

Central nervous system.Vasculitis

Identifiers

PMID22379458
PMCPMC3151598
OpenAlexW2032870707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.